- Home
- QSI vs TLSA Comparison
QSI vs TLSA Comparison
Compare QSI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- TLSA
- Stock Information
- Founded
- QSI 2013
- TLSA 2013
- Country
- QSI United States
- TLSA United Kingdom
- Employees
- QSI N/A
- TLSA N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- TLSA Health Care
- Exchange
- QSI Nasdaq
- TLSA Nasdaq
- Market Cap
- QSI 226.8M
- TLSA 240.0M
- IPO Year
- QSI N/A
- TLSA 2000
- Fundamental
- Price
- QSI $2.15
- TLSA $1.92
- Analyst Decision
- QSI Strong Buy
- TLSA
- Analyst Count
- QSI 3
- TLSA 0
- Target Price
- QSI $2.88
- TLSA N/A
- AVG Volume (30 Days)
- QSI 18.7M
- TLSA 343.6K
- Earning Date
- QSI 11-05-2025
- TLSA 05-06-2025
- Dividend Yield
- QSI N/A
- TLSA N/A
- EPS Growth
- QSI N/A
- TLSA N/A
- EPS
- QSI N/A
- TLSA N/A
- Revenue
- QSI $3,412,000.00
- TLSA N/A
- Revenue This Year
- QSI N/A
- TLSA N/A
- Revenue Next Year
- QSI $219.33
- TLSA N/A
- P/E Ratio
- QSI N/A
- TLSA N/A
- Revenue Growth
- QSI 100.47
- TLSA N/A
- 52 Week Low
- QSI $0.61
- TLSA $0.63
- 52 Week High
- QSI $5.77
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- QSI 54.47
- TLSA 47.88
- Support Level
- QSI $2.02
- TLSA $1.78
- Resistance Level
- QSI $2.44
- TLSA $2.04
- Average True Range (ATR)
- QSI 0.26
- TLSA 0.16
- MACD
- QSI -0.05
- TLSA -0.02
- Stochastic Oscillator
- QSI 16.67
- TLSA 33.33
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.